How to Get Rid of a Staph Infection in Your Nose

Nasal staph infections are typically treated with a prescription antibiotic ointment called mupirocin, applied inside the nostrils for five to seven days. This clears the bacteria in most people within a few weeks, though relapses within several months are common. Whether you’re dealing with an active infection with visible sores and crusting or you’ve been told you’re a nasal carrier of Staphylococcus aureus, the treatment approach differs in important ways, and understanding the difference is the first step toward getting rid of it for good.

Carrying Staph Versus Having an Infection

Many people who learn they have staph in their nose don’t actually have an infection in the traditional sense. They’re colonized, meaning the bacteria live there without causing symptoms. Roughly 20% of people carry S. aureus in their nose persistently, while about 60% carry it on and off, and the remaining 20% almost never carry it at all.¹ A more recent large-scale study found a somewhat different split, with about 28% persistent carriers and 54% non-carriers, but the core pattern holds: a sizable minority of the population walks around with staph in their nose and never knows it.²

The distinction matters because persistent carriers face meaningfully higher risks. In people on peritoneal dialysis, for instance, persistent nasal carriage was associated with roughly three and a half times the rate of dialysis-related infections compared to non-carriers, while intermittent carriers showed no significant increase in risk.³ More broadly, research has shown that over 80% of hospital-acquired staph bloodstream infections are caused by the same strain the patient was already carrying in their nose.⁴ So the bacteria sitting quietly in your nose can be the source if an invasive infection develops later.

An active nasal infection, by contrast, usually means nasal vestibulitis: redness, swelling, crusting, or small boils just inside the nostrils. A retrospective study of 118 cases found that the majority of patients developed mid-facial cellulitis and nearly half had an abscess of the nasal vestibule. Methicillin-sensitive S. aureus (MSSA) was the most common bacterium cultured, showing up in over 80% of cases where cultures were taken.⁵ If you have pain, visible sores, or spreading redness around your nose, you’re past the colonization stage and need treatment promptly.

Mupirocin Ointment and How It Works

The standard first-line treatment for nasal staph, whether you’re clearing colonization or treating a mild infection, is mupirocin ointment (sold under the brand name Bactroban Nasal, among others). Your doctor will typically prescribe a 2% mupirocin nasal ointment applied to each nostril two to three times daily for five days. You squeeze a small amount onto a cotton swab or your fingertip, apply it just inside the nostril, then pinch the nostrils together to spread the ointment around.

Mupirocin is effective at removing S. aureus from the nose over a few weeks, but relapses are common within several months.⁶ A meta-analysis of randomized trials found that mupirocin-based decolonization reduced nasal colonization substantially, with even better results when used in confirmed carriers and combined with an antiseptic body wash like chlorhexidine.⁷ That combination of nasal mupirocin plus chlorhexidine body wash has become the go-to decolonization protocol in many hospitals, particularly before surgery.

For people with recurrent staph skin infections, a monthly application schedule has shown real benefits. In a year-long trial comparing mupirocin to placebo in staph carriers, the mupirocin group had roughly a quarter as many positive nasal cultures and less than half as many skin infections.⁸ This suggests that periodic retreatment can keep colonization suppressed, though it raises a separate concern about resistance with long-term use.

Mupirocin Resistance and Why It Matters

Because mupirocin is used so widely, resistance has been creeping up. A study among healthcare workers at a tertiary care hospital found that while all methicillin-sensitive staph isolates remained fully susceptible to mupirocin, some MRSA isolates had developed resistance.⁹ The numbers in that particular study were small, but the pattern has been documented in hospitals around the world, especially where mupirocin is used routinely for decolonization. If you’ve used mupirocin multiple times and your staph keeps coming back, it’s worth asking your doctor whether your strain might be resistant.

Povidone-Iodine as an Alternative

For people who can’t use mupirocin or whose strain is resistant to it, povidone-iodine nasal preparations offer a different approach. Unlike mupirocin, which is an antibiotic targeting a specific bacterial process, povidone-iodine works as a broad-spectrum antiseptic. Bacteria have a much harder time developing resistance to it because it attacks cells through multiple mechanisms simultaneously.

Lab and human-subject studies have found that a surgical-grade nasal povidone-iodine preparation significantly reduces staph in the nostrils, including MRSA strains that are resistant to mupirocin.¹⁰ In a clinical setting, a randomized trial found that a specially formulated nasal antiseptic containing povidone-iodine brought staph-positive cultures down to 21% at four hours post-treatment, compared to 59% in the saline control group. However, by 24 hours the groups were no longer significantly different.¹¹ That short-lived effect makes povidone-iodine especially useful as a presurgical preparation rather than a long-term decolonization strategy. For surgical prevention, it has been shown to reduce infections effectively in elective orthopedic procedures.¹²

When You Need Oral Antibiotics

Topical mupirocin handles most nasal staph situations, but your doctor may prescribe oral antibiotics if you have a more aggressive infection with spreading redness, fever, or abscess formation. For MRSA nasal infections, the antibiotics typically used include doxycycline and trimethoprim-sulfamethoxazole, sometimes combined with mupirocin nasal rinses. A study treating chronic sinus infections caused by MRSA used exactly this approach, pairing mupirocin irrigations with either doxycycline or trimethoprim-sulfamethoxazole.¹³

If you notice your nasal infection spreading to the surrounding skin of your face, or if you develop a fever, see a doctor quickly. The central part of the face drains into veins that connect to structures inside the skull, and while it’s rare, untreated facial staph infections can lead to serious complications. An abscess or rapidly spreading cellulitis around the nose warrants urgent medical attention, not just a tube of ointment.

Habits That Keep Reintroducing Staph

If you keep getting recolonized after treatment, your own behavior may be part of the problem. Nose picking is a surprisingly well-documented risk factor. A study of hospital patients and healthy volunteers found that nose pickers were about 50% more likely to carry S. aureus, and that the self-reported frequency of nose picking correlated with both how often cultures came back positive and how much staph was present.¹⁴ Among university students, nose picking and shared dormitory living were both significantly linked to higher rates of MRSA nasal carriage.¹⁵

The mechanism is straightforward. Fingers carry staph from other body sites (the skin, the groin, the throat) and reintroduce it into the nose. They also create tiny abrasions in the nasal lining that give bacteria a foothold. Other behaviors flagged in clinical studies as risk factors for nasal vestibulitis include nasal hair plucking, aggressive nose blowing, and nose piercing.⁵ If you’ve been treated for nasal staph more than once, these habits are worth addressing honestly.

Why Staph Keeps Coming Back and the Household Problem

Recurrence is the most frustrating part of dealing with nasal staph. You complete a course of mupirocin, your cultures come back clean, and then within a few months the bacteria are back. One reason is that staph doesn’t just live in your nose. It can colonize your throat, groin, armpits, and skin creases, and a nasal swab alone only catches about half of all MRSA carriers.¹⁶ The bacteria that survived at another body site simply migrate back to the nose once treatment stops. This is why the combination of nasal mupirocin plus chlorhexidine body wash performs better than nasal treatment alone.

The other major source of recolonization is your household. Staph infections cluster within families, and asymptomatic carriers serve as reservoirs for ongoing transmission. Research has consistently shown that a household-wide approach to decolonization is more effective than treating one person in isolation.¹⁷ The bacteria can also persist on household surfaces and shared items like towels, razors, and bedding, creating additional reservoirs. Even with household-wide efforts, interventions designed to reduce recurrence among household members have had limited success, likely because there are simply too many potential sources for recolonization.¹⁸

Practical steps to reduce household spread include washing towels and bed linens in hot water, not sharing razors or personal care items, wiping down frequently touched surfaces, and having all household members use the chlorhexidine body wash during the decolonization period. None of these are guaranteed to prevent recolonization, but they reduce the bacterial load in the environment.

The Presurgical Context

If you’ve been told to clear nasal staph before a scheduled surgery, your situation is somewhat different from someone treating recurring skin infections. Hospitals screen for staph carriage before major operations because surgical patients who carry the bacteria in their nose face a higher risk of wound infections caused by their own strain. A health technology assessment by Ontario Health concluded that decolonization using nasal mupirocin combined with chlorhexidine body wash before cardiac, vascular, orthopedic, gastrointestinal, or general surgery lowers the rate of staph-caused surgical site infections in confirmed carriers.¹⁹

In this context, the short-lived action of povidone-iodine is actually an advantage. You don’t need to clear the bacteria permanently; you just need a sterile field during and immediately after the procedure. Some surgical centers now use nasal povidone-iodine applied in the hours before the operation, sometimes in combination with mupirocin in the days leading up to it. The mupirocin-based meta-analysis found that the benefits were largest when decolonization was targeted to confirmed carriers rather than applied universally to all surgical patients.⁷

What the Nasal Microbiome Has to Do With It

Your nose isn’t just a battlefield between you and staph. It’s an ecosystem. Dozens of bacterial species compete for space and resources in the nasal passages, and certain harmless residents can interfere with staph colonization.²⁰ Large-scale microbiome studies have found that people who persistently carry S. aureus in their nose tend to have lower diversity in their nasal bacterial community and notably fewer Corynebacterium species, Dolosigranulum pigrum, and Staphylococcus epidermidis.²

This has prompted experiments in bacterial interference, essentially introducing competing bacteria to push staph out. In one study, researchers implanted a strain of Corynebacterium into the noses of 17 S. aureus carriers and completely eradicated the staph in 71% of them.²¹ It’s a small, early study, but the idea of using “good” bacteria to outcompete staph rather than blasting the entire nasal ecosystem with antibiotics is appealing, especially for people who keep relapsing.

There’s also an individual genetic component. Genome-wide studies have identified specific gene variants associated with persistent nasal carriage, including genes involved in immune signaling, antimicrobial peptide production, and vitamin D receptors.²² This may partly explain why some people seem to get recolonized no matter what they do: their nasal environment, shaped by genetics, is simply more hospitable to S. aureus.

Tea Tree Oil and Other Non-Prescription Approaches

You’ll find tea tree oil recommended on many health forums as a natural alternative for nasal staph. There is a small amount of clinical evidence behind this. A trial comparing a 4% tea tree oil nasal ointment (paired with a 5% tea tree oil body wash) to the standard mupirocin-plus-triclosan protocol found that the tea tree oil combination appeared to perform as well or better, though the difference was not statistically significant because the study was too small.²³ That’s an encouraging signal, but “not enough evidence to be sure it works” is very different from “proven to work.” If you want to try tea tree oil, be aware that pure essential oil can irritate the nasal lining, and commercial tea tree nasal preparations with standardized concentrations are the safer route.

Saline nasal rinses, petroleum jelly, and dilute hydrogen peroxide solutions are also sometimes suggested. Saline rinses can help flush crusts and debris from infected nostrils, and they showed up as the control arm in several of the clinical studies cited here, performing worse than active treatments but providing some mechanical benefit. None of these are substitutes for mupirocin when you have an active infection or confirmed persistent carriage with a history of complications.

Bacteriophage Therapy on the Horizon

One emerging treatment that generates a lot of buzz is bacteriophage therapy, using viruses that specifically infect and kill bacteria. A small safety trial treated nine patients who had chronic sinus infections caused by S. aureus with a phage preparation applied directly to the sinuses. All patients had a reduction in staph growth, and two of nine had completely negative cultures after treatment.²⁴ The study was designed to test safety, not effectiveness, so these numbers are preliminary at best. But phage therapy is attractive for the same reason as microbiome-based approaches: it’s targeted, potentially sparing the rest of your nasal flora, and bacteria that develop resistance to one phage can often be attacked by a different one. For now, phage therapy is not commercially available for nasal staph outside of a handful of specialized centers and clinical trials, but it represents where the field is heading for patients who have exhausted conventional options.

1
PubMed Central. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
2
PubMed Central. Large-scale characterisation of the nasal microbiome redefines Staphylococcus aureus colonisation status
3
PubMed. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections
4
FEMS Microbiology Reviews. Staphylococcal trafficking and infection—from ‘nose to gut’ and back
5
PubMed. Nasal vestibulitis: etiology, risk factors, and clinical characteristics: A retrospective study of 118 cases
6
Journal of Antimicrobial Chemotherapy. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects
7
PubMed. Mupirocin-based nasal decolonization to prevent Staphylococcus aureus surgical site infections: A meta-analysis of randomized control trials
8
PubMed. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection
9
PubMed Central. Mupirocin resistance in nasal carriage of Staphylococcus aureus among healthcare workers of a tertiary care rural hospital
10
PubMed Central. Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares
11
PubMed. Povidone-Iodine-Based Solutions for Decolonization of Nasal Staphylococcus aureus: A Randomized, Prospective, Placebo-Controlled Study
12
American Journal of Infection Control. What Is the Impact of Prophylactic Nasal Decolonization in Prevention of SSI?
13
PubMed. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations
14
PubMed. Nose picking and nasal carriage of Staphylococcus aureus
15
PubMed Central. Nasal carriage of MRSA among clinically affiliated undergraduate students at the College of Health and Medical Sciences, Haramaya University, Ethiopia
16
PubMed Central. Screening for methicillin-resistant Staphylococcus aureus colonization using sponges
17
PubMed Central. Prevention of Recurrent Staphylococcal Skin Infections
18
PubMed Central. Staphylococcus aureus infections: transmission within households and the community
19
PubMed Central. Pre-surgical Nasal Decolonization of Staphylococcus aureus: A Health Technology Assessment
20
PubMed Central. Nutritional Interactions between Bacterial Species Colonising the Human Nasal Cavity: Current Knowledge and Future Prospects
21
PubMed. Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp.
22
PubMed. Complex host genetic susceptibility to Staphylococcus aureus infections
23
PubMed. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus
24
JAMA Otolaryngology–Head & Neck Surgery. Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus